Clinical Trials Directory

Trials / Completed

CompletedNCT01104740

Dengue Seroprevalence Study in Blood Donors in the French West Indies

Status
Completed
Phase
Study type
Observational
Enrollment
817 (actual)
Sponsor
Etablissement Français du Sang, Martinique · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Dengue is an infectious disease most prevalent in the world. This disease is endemic in the Caribbean, with an increase in seasonal rains. Several outbreaks have been observed in recent years, in 2001, 2005 and 2007, during which further particularly virulent serotypes have emerged. The clinical expression of dengue fever is variable, ranging from no symptoms to a classical form with fever, and even of severe or lethal bleeding. With the possible existence of silent forms of the disease, there are no data identifying the current level of protection of the population in Martinique / Guadeloupe.

Detailed description

1. Principal objective: To estimate the prevalence of the specific antibodies of the dengue (IgG) in blood donors in the French West Indies. 2. Secondary objective: To specify the serotypic specificity of the anti-dengue antibodies detected during the study.

Conditions

Interventions

TypeNameDescription
OTHERBiological sample collectionBlood (serum) sample collection

Timeline

Start date
2011-05-01
Primary completion
2011-05-01
Completion
2012-05-01
First posted
2010-04-15
Last updated
2021-08-20

Locations

2 sites across 2 countries: Guadeloupe, Martinique

Source: ClinicalTrials.gov record NCT01104740. Inclusion in this directory is not an endorsement.